Liver graft protection by antiapoptotic drugs: a step further.
Georgiev
Panco
P
Clavien
Pierre A
PA
Gores
Gregory J
GJ
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D016031:Liver Transplantation / Q000379:methods* / Q000473:pathology; D009926:Organ Preservation / Q000379:methods; D019188:Organ Preservation Solutions / Q000494:pharmacology; D010421:Pentanoic Acids / Q000494:pharmacology*; D051381:Rats; D015427:Reperfusion Injury / Q000473:pathology / Q000517:prevention & control; D013696:Temperature; D016896:Treatment Outcome
C487112:3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid; D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors; D019188:Organ Preservation Solutions; D010421:Pentanoic Acids